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Optimizing Transcatheter
Aortic Valve Sizing
and Minimizing
Vascular Complications*
Carlos E. Ruiz, MD, PHD
New York, New York
Percutaneous aortic valve replacement (PAVR) is an excep-
tionally innovative procedure that will undoubtedly alter the
way we treat patients with severe aortic stenosis. A proce-
dure once reliant on the operative visual information and
feedback afforded to the cardiovascular surgeon is now
supplanted by a multitude of imaging technologies available
to the interventional cardiologist. Already since the advent
of this technology, interventionists have become more
cognizant of the intricate anatomopathological relationships
of the aortic valve complex. Unfortunately to date, no single
imaging modality provides all of the necessary anatomical
and functional information needed for safe and effective
transcatheter valve implantation. It is now more imperative
for us to be aware of the many different imaging modalities
available and to be able to integrate their varied information
in order to more accurately plan and deliver transcatheter
prosthetic valves.
See pages 113 and 119
Currently, there are 2 transcatheter prosthetic valves that
are commercially available outside the United States. Both
valves have different profiles and mechanical properties.
One valve is designed on a balloon-expandable frame with
the coaptation line of the leaflets at the native annular
level; the other valve is designed on a self-expandable
frame with the coaptation line of the leaflets in a supra-
annular level. Optimizing prosthesis selection should be
based on matching the physiomechanical properties of the
device intended with the anatomical and mechanical char-
acteristics of the patient’s cardiovascular structures. Regard-
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Accurately defining the anatomic and mechanical properties
of the cardiovascular structures is a necessity. This process
begins by choosing the safest access site to minimize
vascular complications and to effectively deliver the valve.
Monoplanar measurements of the inner luminal diameters
of the access vessels alone is clearly inadequate. The
degree of tortuosity, angulation, and the location and
quantification of vessel calcification must all be taken into
consideration. Nonetheless, this information may not be
sufficient to ensure safe passage of the delivery systems. We
lack information on vessel compliance and are unable to
estimate how the vascular structure will reconfigure during
the passage of stiff devices.
In this issue of the Journal, Toggweiler et al. (1) report the
improvement on vascular complications during PAVR in
137 consecutive patients during a 2-year period in a single
institution. Vascular complications occurred in 18% of the
patients, mostly in patients with identifiable vascular disease
(37%). The use of screening multidetector computed tomo-
graphic (MDCT) angiography was progressively incorpo-
rated over the study period and was available in 60% of all
patients. In this group of patients screened with MDCT,
the vessel minimal luminal diameter being smaller than the
sheath external diameter (23% vs. 5%) and the presence of
calcified vessels (29% vs. 9%) were strong predictors for
vascular complications. Major vascular complications de-
creased from 8% to 1% and minor vascular complications
from 24% to 8% over the 2-year study period. The larger
single-center experience of these investigators compared
favorably with the recent PARTNER (Placement of Aortic
Transcatheter Valve) trial, in which major vascular compli-
cations occurred in 16.2% of cohort B (2) and 11% of cohort A
atients (3).
The decrease in vascular complications is multifactorial,
wing to operator experience, device refinement, and fore-
ost patient selection, by assessing the vasculature from the
ccess site to the valve annulus. Although not reported in
heir study, the direct contribution of better image infor-
ation, such as MDCT, may have played a significant role
n decreasing vascular complications during PAVR. Cur-
ently, most interventionists rely on plain angiography and/or CT
echnologies to assess inner lumen diameters, tortuosity, and
alcification of the vasculature. These methodologies trust single-
iameter measurements of a 2-dimensional (2D) planar image,
nless curve multiplanar reconstruction and 3-dimensional (3D)
essel analysis is performed. Perhaps routine 3D imaging
nterpretation could enhance the accuracy of vessel assess-
ent. Yet imaging alone may not provide all the necessary
nformation to significantly improve patient selection. Me-
hanical analysis of the vessels may be necessary. There is no
ubstitute for experience on any type of procedure to
inimize complications. Nonetheless, quantifiable imaging
arameters that can be universally applied will be a major
129JACC Vol. 59, No. 2, 2012 Ruiz
January 10, 2012:128–9 Optimizing Transcatheter Aortic Valve Implantationadvance toward improving success and decreasing PAVR
complications.
The major challenges to a functionally successful valve
implantation remain the proper sizing of the prosthesis for
the intended landing zone and establishing the appropriate
angulation of the delivery system in relation to the annular
plane. Ideally the valve should abolish any degree of ob-
struction between the left ventricle and the aorta, without
resultant valvular or paravalvular regurgitation and without
impact on the left ventricular outflow tract mechanics. The
precise assessment required is impossible based solely on 2D
image information; therefore, accurate measurement of this
complex dynamic structure should rely on true 3D image
measurements throughout the cardiac cycle (4-dimensional
with the time factor), combined with hemodynamics. This
would enable us to provide accurate quantifiable informa-
tion on the annular dimensions and angulation while
allowing a simultaneous estimation of the inherent mechan-
ical properties of the aortic valve complex.
Also in this issue of the Journal, Hamdan et al. (4)
assessed the deformation dynamics of the aortic annulus
throughout the cardiac cycle using multiphase reconstruc-
tion of electrocardiogram-gated CT angiograms in 35
patients with severe aortic stenosis undergoing PAVR and
in 11 normal control subjects. Their calculation of the
Young’s elastic modulus, a measure of aortic annular stiff-
ness, relied on pressure data obtained at a different time
interval than the CT image acquisition. They assumed
many other important factors that make their data a vague
quantitative expression of the annular mechanical proper-
ties. They describe the dynamic conformational changes
that occur throughout the cardiac cycle of the aortic annu-
lus, reshaping its elliptical shape in diastole to a more
rounded shape in systole, to increase the cross-sectional flow
area. This change occurs without a significant variation in
the perimeter size, especially in patients with calcific aortic
stenosis. The authors conclude that accurate measurement
of the perimeter is therefore ideally suited for determining
appropriate prosthesis size. This proposed methodology for
sizing valve prosthesis obviates the need to depend on
multiple size diameter measurements of a predominately
elliptical-shape plane. Accommodation of a round prosthe-
sis into a calcified elliptical annulus increases the risk of
valve under-sizing or over-sizing depending on which di-
ameter measurement is used. Inappropriate prosthesis size
not only may result in embolization/migration of the pros-
thesis (5,6), but can also cause annular rupture (7,8), aortic
dissection (9,10), and paravalvular leaks (11,12). Neverthe-
less, even when the perimeter of the annular plane is closely
matched to the intended valve prosthesis, the mechanical
response of the native tissue to the stress of the valve
deployment cannot be predicted on the basis of imaging
alone. The incorporation of hemodynamic data to thevolumetric image acquisition during the cardiac cycle may
add further understanding into the mechanical properties of
the cardiovascular structures and assist in the valve selection
process.
These 2 studies provide support for a rational integrated
imaging strategy when assessing PAVR candidates. Guess-
ing is defined as a prediction without sufficient information
or knowledge. If we are to achieve improved safety and
accuracy in PAVR, we must demand more relevant multi-
imaging information to minimize the need for guessing.
Eventually, all of this needed information will be accurately
quantifiable and displayed in real-time 3D to provide
similar, if not better, feedback compared with the surgeons’
experience in the operating room.
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